Geovax Labs Inc (GOVX)
2.95
+0.25
(+9.26%)
USD |
NASDAQ |
Nov 22, 16:00
2.91
-0.04
(-1.36%)
After-Hours: 20:00
Geovax Labs Cash from Investing (Quarterly): -0.0207M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.0207M |
| June 30, 2024 | 0.00 |
| March 31, 2024 | |
| December 31, 2023 | -0.0189M |
| September 30, 2023 | -0.0062M |
| June 30, 2023 | -0.0238M |
| March 31, 2023 | |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -0.0519M |
| June 30, 2022 | -0.0202M |
| March 31, 2022 | -0.0622M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | -0.0278M |
| June 30, 2021 | -0.0199M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | -0.1543M |
| September 30, 2020 | -0.0025M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | -0.0033M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | -0.0043M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | -0.0043M |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | -0.0158M |
| December 31, 2014 | 0.00 |
| September 30, 2014 | -0.0243M |
| June 30, 2014 | -0.0112M |
| March 31, 2014 | 0.00 |
| December 31, 2013 | -0.00 |
| September 30, 2013 | -0.0866M |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.1543M
Minimum
Dec 2020
--
Maximum
Mar 2020
-0.0229M
Average
-0.0126M
Median
Cash from Investing (Quarterly) Benchmarks
| Abbott Laboratories | -594.00M |
| Emergent BioSolutions Inc | 112.00M |
| Tonix Pharmaceuticals Holding Corp | -0.009M |
| SIGA Technologies Inc | -0.0224M |
| Chimerix Inc | 28.32M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.297M |
| Cash from Financing (Quarterly) | 16.35M |
| Free Cash Flow | -27.24M |
| Free Cash Flow Per Share (Quarterly) | -1.455 |
| Free Cash Flow to Equity (Quarterly) | -9.176M |
| Free Cash Flow Yield | -277.9% |